Navigation Links
Veridiam Names Robert Mazzacavallo New CFO
Date:11/3/2009

SAN DIEGO, Nov. 3 /PRNewswire/ -- Robert Mazzacavallo has joined Veridiam as the company's Chief Financial Officer. San Diego-based Veridiam is a contract manufacturer of high-precision, fabricated assemblies and metal components, primarily serving Fortune 500 companies in the medical devices, power generation, aerospace and general industrial markets.

Before joining Veridiam, Mazzacavallo was Chief Financial Officer at C-Tech Industries in Camas, WA. At C-Tech, Bob worked closely with Andrew Gale, now Veridiam's CEO. Mazzacavallo has spent much of his career assisting mid-sized, multi-site manufacturers grow their business, identify efficiencies, streamline processes and optimize resources.

"Andy Gale has a strong achievable vision for the company and I am looking forward to helping to drive that vision and make it a reality," he continues. "My part in this is to help improve efficiencies, drive out costs and help make Veridiam an even greater success than it is today."

"Among our customers and our competitors, Veridiam is recognized for its unique capabilities and solid reputation for quality," he says. "Veridiam is a gem of a company. I am really excited to be a part of it and to help build upon its successes going forward."

Mazzacavallo sees particular growth potential in nuclear power generation--an industry that Veridiam has been involved in since 1958. "Our capabilities in this area are second to none and our customers are the industry's leaders."

The medical device market also holds tremendous growth potential for Veridiam, Mazzacavallo believes. "Our medical device business has continued to thrive and grow, even in a down economy. We expect this area to expand significantly."

Mazzacavallo holds an MBA in Finance from University of Michigan's Stephen M. Ross School of Business and a BBA in Accounting from University of Notre Dame.

Veridiam, headquartered in El Cajon, CA has two manufacturing facilities in San Diego, CA and a third in San Jose, Costa Rica. Customers include General Electric, Solar Turbines, Hitachi, Toshiba, Boeing, Westinghouse, AREVA, Hologic, Pioneer Surgical and Medtronics. For additional information about Veridiam, visit www.veridiam.com.

SOURCE Veridiam


'/>"/>
SOURCE Veridiam
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Names Daphne E. Jones Chief Information Officer
2. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
3. American Hospital Association (AHA) Names OnBase RACTrac Compatible
4. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
5. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
6. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
7. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
8. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
9. California Cryobank Names Richard Jennings President of FamilyCord Division
10. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
11. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):